Salvatore Grisanti

Bevacizumab as adjuvant for neovascular glaucoma.

Current and future therapies for age-related macular degeneration.

Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients.

The safety profile of alkylphosphocholines in the model of the isolated perfused vertebrate retina.

Effects of pegaptanib sodium on retinal function in isolated perfused vertebrate retina.

The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR).

Regression of rubeosis in the fellow eye after intravitreal ranibizumab injection.

Histologic basis of variations in retinal pigment epithelium autofluorescence in eyes with geographic atrophy.

Morphological and functional outcome after brilliant blue G-assisted macular hole surgery.

Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma--results from a prospective interventional case series.

The neuroprotective potential of Rho-kinase inhibition in promoting cell survival and reducing reactive gliosis in response to hypoxia in isolated bovine retina.

The retinal biocompatibility of dyes in the ex vivo model of the isolated superfused vertebrate retina.

The concentration-dependent effects of indocyanine green on retinal function in the electrophysiological ex vivo model of isolated perfused vertebrate retina.

Identification of circulating melanoma cells in uveal melanoma patients by dual-marker immunoenrichment.

Testing the effects of the dye acid violet-17 on retinal function for an intraocular application in vitreo-retinal surgery.

The effect of disease-modifying antirheumatic drugs on retinal function in the electrophysiological ex vivo model of the isolated perfused vertebrate retina.

Analysis of caveolin-1 and phosphoinositol-3 kinase expression in primary uveal melanomas.

Ranibizumab interacts with the VEGF-A/VEGFR-2 signaling pathway in human RPE cells at different levels.

CD147 and matrix-metalloproteinase-2 expression in metastatic and non-metastatic uveal melanomas.

Analysis of monosomy-3 in immunomagnetically isolated circulating melanoma cells in uveal melanoma patients.

Introducing MARCo: Histoserological Findings of a Multi-Organic Paraneoplastic Syndrome in Cutaneous Melanoma Patients.

Stereotactic radiotherapy in neovascular age-related macular degeneration: Real-life efficacy and morphological evaluation of the outer retina-choroid complex.

The effect of anakinra on retinal function in isolated perfused vertebrate retina.

Testing the clinical value of multifocal electroretinography and microperimetry and the effects of intravitreal therapy with ranibizumab on macular function in the course of wet age-related macular degeneration: a 1-year prospective study.

Peripheral Hypertrophic Subepithelial Corneal Degeneration.

Changes in Peripapillary Nerve Fiber Layer Thickness after Adjuvant Stereotactic Radiotherapy in Patients with Neovascular Age-Related Macular Degeneration.

ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch's Membrane and Causes Its Structural Remodeling.

Intravitreal decorin preventing proliferative vitreoretinopathy in perforating injuries: a pilot study.

Evaluation of retinal microvascular perfusion in systemic sclerosis: a case-control study.

Apolipoprotein A-I Mimetic Peptide L-4F Removes Bruch's Membrane Lipids in Aged Nonhuman Primates.

Subfoveal choriocapillaris, Sattler's and Haller's layer thickness predict clinical response to stereotactic radiotherapy in neovascular age-related macular degeneration patients.

Evaluating diurnal changes in choroidal sublayer perfusion using optical coherence tomography angiography.

Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities.

Fluorescence Lifetime Imaging Ophthalmoscopy of the Retinal Pigment Epithelium During Wound Healing After Laser Irradiation.

[Uveal melanoma : Early detection as the key to successful personalized medicine].

Corneal Allograft Treatment for Conjunctival Erosion Caused by Electronic Retinal Implant.